Genome Editing with IscB-ωRNA

August 9, 2022 | | Posted in Newsletter

Genome Editing with IscB-ωRNA
“In new research, Cornell scientists provide an explanation for how this problem [i.e. the large size of [MORE]

How Long Does Gene Editing Last?

May 17, 2022 | | Posted in Newsletter

How long doe gene editing last?
“. . . Intellia [Cambridge, MA] is presenting additional data from the phase 1 trial [MORE]

Gene Editing of Endothelial Cells

March 22, 2022 | | Posted in Newsletter

Gene Editing of Endothelial Cells
“To target endothelium for robust genome editing, we developed poly(ethylene glycol) methyl ether-block-poly(lactide-co-glycolide) (PEG-b-PLGA) copolymer-based nanoparticle [MORE]

Gene Editing for DNA Repair

December 21, 2021 | | Posted in Newsletter

Enhanced prime editing systems
“Toward the goal of enabling a wide range of sequence changes, we [a collaboration of Broad Institute, [MORE]

Engineered Cells Implanted to Reduce Inflammation

November 16, 2021 | | Posted in Newsletter

Implant scaffold with engineered cells release drug to treat inflammation
Building on their work with anti-inflammatory cartilage cells, researchers at Washington [MORE]

Another Win for CRISPR

October 26, 2021 | | Posted in Newsletter

CRISPR therapy for rare blood diseases
“Back in 2019 the first CRISPR human clinical trials kicked off in the United States. [MORE]

Genetic Screening of Organoids

January 19, 2021 | | Posted in Newsletter

CRISPR-LIGHT tool for genetic screening tool for organoids
CRIPSR-Lineage Tracing at Cellular resolution in Heterogeneous Tissue (CRISPR-LICHT) is the term researchers [MORE]

CRISPR’s Thirteen Different Cas 9 Cutting Enzymes

August 11, 2020 | | Posted in Newsletter

Crispr Cas9 molecular scissors
Computational biologists at the Institute for Basic Science (Daejeon, South Korea) have identified thirteen different variations of [MORE]

CRISPR Applied to Disease Prevention

February 18, 2020 | | Posted in Newsletter

Genetic modifiers science chart
“Based in San Francisco, Maze Therapeutics (Maze) is studying modifier genes—genes that affect the phenotype or physical [MORE]

Anti-Resistance Plasmid

January 14, 2020 | | Posted in Newsletter

Genetically engineered plasmid with-CRISPR-Cas9 removes-Antibiotic Resistance Gene
In a collaboration between plasmid engineers at the University of Colorado SOM and the [MORE]

Human Clinical Trials for CRISPR Underway in the US

November 26, 2019 | | Posted in Newsletter

Seven years after CRISPR-Cas9 gene editing appeared, clinical trials have begun.  The University of Pennsylvania has treated two patients, [MORE]

CRISPR as a Genetic Search Engine

June 25, 2019 | | Posted in Newsletter

Crispr Cas9 protein RNA complex
Heretofore, most of the news about CRISPR was about gene editing, unintended off targeting, and the [MORE]

First Cancer Trial for CRISPR

June 11, 2019 | | Posted in Newsletter

Multiple myeloma cells
Calling the first use of CRISPR gene editing to treat cancer “a genetic Sputnik”, though this time it [MORE]

Regenerative Medicine’s Gene Editing Toolbox

April 23, 2019 | | Posted in Newsletter

CRISPR Cas9 Editing_ of the Genome
Scientists at the Wake Forest Institute for Regenerative Medicine have figured out how to control [MORE]